EMAIL THIS PAGE TO A FRIEND

R8781 Sigma

Rapamycin

Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus

Synonym: 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine solution

Properties

Related Categories Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Cell Biology, Pfizer Compounds
Quality Level   PREMIUM
biological source   from Streptomyces hygroscopicus
sterility   0.2 μm filtered
assay   ≥95% (HPLC)
concentration   2.5 mg/mL in DMSO (2.74 mM)
storage temp.   −20°C

Description

Biochem/physiol Actions

Rapamycin is a macrocyclic triene antibiotic possessing potent immunosuppressant and anticancer activity. It forms a complex with FKBP12 that binds to and inhibits the molecular target of rapamycin (mTOR). mTOR is a member of the phosphoinositide kinase-related kinase (PIKK) family that enhances cellular proliferation via the phosphoinositol 3-kinase/Akt signaling pathway. Inhibition of this pathway by rapamycin blocks downstream elements that result in cell cycle arrest in G1. The effectors of mTOR action include 4EBP1 and S6K1.

Features and Benefits

This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Protocols & Applications

Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information

Price and Availability

Additional Products to Explore

3-Methyladenine

autophagy inhibitor

LY-294,002 hydrochloride

solid, ≥98% (HPLC)

Rapamycin

VETRANAL, analytical standard

Customers Also Viewed

3-Methyladenine

autophagy inhibitor

Rapamycin

VETRANAL, analytical standard

Temsirolimus

≥98% (HPLC)

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?